Page last updated: 2024-08-24

simendan and Hypotension

simendan has been researched along with Hypotension in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (42.86)	29.6817
2010's	5 (35.71)	24.3611
2020's	3 (21.43)	2.80

Authors

Authors	Studies
Li, M; Li, Y; Qu, T; Wan, Q; Yuan, F; Zhang, Y	1
Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML	1
Luo, B; Wang, M	1
Elhassan, A; Essandoh, M	1
Dempsey, E; Rabe, H	1
Huang, LQ; Huang, X; Jiang, RL; Lei, S; Xia, GL; Zhi, YH; Zhu, MF	1
Economides, C; Kota, B; Prasad, AS; Singh, BN	1
Abraham, MK; Barrueto, F; Meltzer, A; Scott, SB	1
Blomquist, S; Cunha-Goncalves, D; Dahm, PL; Grins, E; Perez-de-Sa, V; Thörne, J	1
Blomquist, S; Cunha-Goncalves, D; Larsson, A; Perez-de-Sa, V; Thörne, J	1
Cataldi, L; Toth-Heyn, P	1
Arocas-Casañ, V; Blázquez-Álvarez, MJ; Cárceles-Barón, MD; de la Rubia-Nieto, A; Fernández de Palencia-Espinosa, MA	1
Andrejevs, N; Golikov, AP; Kobalava, ZD; Laine, T; Lazebnik, LB; Lehtonen, LA; Lie, KI; Moiseyev, VS; Nieminen, MS; Põder, P; Ruda, MY	1
Andrade, AC; Mebazaa, A; Tavares, M	1

Reviews

5 review(s) available for simendan and Hypotension

Article	Year
The Use of Cardiotonic Drugs in Neonates. Clinics in perinatology, 2019, Volume: 46, Issue:2 Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Intensive Care Units, Neonatal; Milrinone; Neonatal Sepsis; Norepinephrine; Persistent Fetal Circulation Syndrome; Shock; Simendan; Vasoconstrictor Agents; Vasopressins	2019
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. Journal of Zhejiang University. Science. B, 2013, Volume: 14, Issue:5 Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Comorbidity; Critical Illness; Dobutamine; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Hypotension; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Simendan; Survival Rate; Treatment Outcome	2013
Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure. Journal of cardiovascular pharmacology and therapeutics, 2008, Volume: 13, Issue:4 Topics: Calcium; Cardiotonic Agents; Contractile Proteins; Headache; Heart Failure; Humans; Hydrazones; Hypotension; Myocardium; Pyridazines; Randomized Controlled Trials as Topic; Simendan	2008
Vasoactive compounds in the neonatal period. Current medicinal chemistry, 2012, Volume: 19, Issue:27 Topics: Adrenal Cortex Hormones; Cardiovascular System; Catecholamines; Humans; Hydrazones; Hypotension; Infant, Newborn; Milrinone; Pyridazines; Simendan; Vasodilator Agents; Vasopressins	2012
Levosimendan use in several scenarios of acute heart failure. Arquivos brasileiros de cardiologia, 2008, Volume: 90, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Contraindications; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypotension; Ischemia; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Syndrome; Vasodilator Agents	2008

Trials

2 trial(s) available for simendan and Hypotension

Article	Year
Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study. BMC cardiovascular disorders, 2022, 03-29, Volume: 22, Issue:1 Topics: Cardiotonic Agents; Drugs, Chinese Herbal; Heart Failure; Humans; Hydrazones; Hypotension; Prospective Studies; Pyridazines; Simendan; Single-Blind Method	2022
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). European heart journal, 2002, Volume: 23, Issue:18 Topics: Acute Disease; Aged; Analysis of Variance; Cardiotonic Agents; Double-Blind Method; Drug Evaluation; Endpoint Determination; Female; Heart Failure; Humans; Hydrazones; Hypotension; Male; Myocardial Infarction; Prospective Studies; Pyridazines; Risk Factors; Safety; Simendan; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left	2002

Article

Year

Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study.

BMC cardiovascular disorders, 2022, 03-29, Volume: 22, Issue:1

Topics: Cardiotonic Agents; Drugs, Chinese Herbal; Heart Failure; Humans; Hydrazones; Hypotension; Prospective Studies; Pyridazines; Simendan; Single-Blind Method

2022

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

European heart journal, 2002, Volume: 23, Issue:18

Topics: Acute Disease; Aged; Analysis of Variance; Cardiotonic Agents; Double-Blind Method; Drug Evaluation; Endpoint Determination; Female; Heart Failure; Humans; Hydrazones; Hypotension; Male; Myocardial Infarction; Prospective Studies; Pyridazines; Risk Factors; Safety; Simendan; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left

2002

Other Studies

7 other study(ies) available for simendan and Hypotension

Article	Year
Levosimendan with other inotropes or vasopressors: Should you combine them? The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents	2020
Levosimendan is safe to patients with advanced heart failure and hypotension. International journal of cardiology, 2021, 09-01, Volume: 338 Topics: Heart Failure; Humans; Hydrazones; Hypotension; Simendan	2021
Inhaled Levosimendan for Pulmonary Hypertension Treatment During Cardiac Surgery: A Novel Application to Avoid Systemic Hypotension. Journal of cardiothoracic and vascular anesthesia, 2019, Volume: 33, Issue:4 Topics: Double-Blind Method; Humans; Hypertension, Pulmonary; Hypotension; Milrinone; Mitral Valve; Pilot Projects; Simendan	2019
Levosimendan does not improve survival time in a rat model of verapamil toxicity. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009, Volume: 5, Issue:1 Topics: Animals; Antidotes; Body Temperature; Bradycardia; Calcium Channel Blockers; Drug Interactions; Electrocardiography; Heart Arrest; Heart Rate; Hydrazones; Hypotension; Male; Models, Animal; Phosphodiesterase Inhibitors; Pyridazines; Rats; Rats, Wistar; Simendan; Time Factors; Verapamil	2009
Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion. Anesthesia and analgesia, 2009, Volume: 109, Issue:5 Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Fluid Therapy; Heart Rate; Hemodynamics; Hydrazones; Hypotension; Lactic Acid; Lipopolysaccharides; Liver Circulation; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Swine; Time Factors; Vascular Resistance	2009
Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine. Anesthesia and analgesia, 2009, Volume: 109, Issue:5 Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Fluid Therapy; Heart Rate; Hemodynamics; Hydrazones; Hypotension; Lactic Acid; Lipopolysaccharides; Liver Circulation; Norepinephrine; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Swine; Time Factors; Vascular Resistance	2009
[Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease]. Revista espanola de anestesiologia y reanimacion, 2012, Volume: 59, Issue:9 Topics: Cardiotonic Agents; Child, Preschool; Comorbidity; Compassionate Use Trials; Coronary Circulation; Down Syndrome; Drug Evaluation; Female; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Hypotension; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Myocardial Ischemia; Postoperative Complications; Potassium Channels; Pyridazines; Retrospective Studies; Salvage Therapy; Simendan; Tachycardia	2012